An adenosine A 2A receptor gene haplotype is associated with migraine with aura
|
|
- June Cox
- 6 years ago
- Views:
Transcription
1 BRIEF REPORT An adenosine A 2A receptor gene haplotype is associated with migraine with aura C Hohoff 1, M Marziniak 2,3, K-P Lesch 4, J Deckert 1, C Sommer 2 & R Mössner 4 1 Department of Psychiatry and Psychotherapy, University of Münster, Münster, 2 Department of Neurology, Julius-Maximilians-University, Würzburg, 3 Department of Neurology, Saarland University, Homburg/Saar and 4 Department of Psychiatry and Psychotherapy, University of Würzburg, Würzburg, Germany Hohoff C, Marziniak M, Lesch K-P, Deckert J, Sommer C & Mössner R. An adenosine A 2A receptor gene haplotype is associated with migraine with aura. Cephalalgia 2007; 27: London. ISSN The adenosine A 2A receptor (A2AR) facilitates effects of calcitonin gene-related peptide and vasoactive intestinal peptide, two important neuropeptides in migraine pathophysiology, and is the molecular target of caffeine, which is used in migraine treatment. We therefore determined whether A2AR gene variation might influence migraine susceptibility. Migraine patients (n = 265) with or without aura and migraine-free controls (n = 154) were assessed and genotyped for six genetic variants spanning the A2AR gene. A six-marker haplotype was more frequent in migraine patients with aura (P < 0.01) but not in patients without aura, compared with the control group. This indicates that A2AR gene variation may contribute to the pathogenesis of migraine with aura. Adenosine A 2A receptor, association study, haplotype, migraine with aura, polymorphisms Dr C. Hohoff, Department of Psychiatry and Psychotherapy, University of Münster, Albert-Schweitzer-Str. 11, D Münster, Germany. Tel , fax , hohoffch@uni-muenster.de Received 16 May 2006, accepted 24 August 2006 Introduction Migraine is a common disorder with a major genetic component and a multifactorial, polygenic mode of inheritance. Genome-wide linkage studies have identified several loci on different chromosomes, but these results are inconsistent except for the rare forms of familial hemiplegic migraine (1, 2). For the more common forms of migraine, genes of the dopamine and serotonin neurotransmitter system have been investigated as candidate genes. In addition, genes of the adenosine system have to be considered as candidate genes, as adenosine receptors appear to be key receptors in the modulation of the action of migraine-related neuropeptides. Two highly selective adenosine A 1 receptor agonists, GR and GR , can inhibit trigeminovascular activation in the trigeminal nucleus and calcitonin gene-related peptide (CGRP) release in the cranial circulation (3). In contrast, the adenosine A 2A receptor (A2AR) facilitates effects of CGRP, released by the terminals of the trigeminal nerve after stimulation of the trigeminal ganglion, vasoactive intestinal polypeptide (VIP), which is a marker for cranial parasympathetic nerve activation (4). VIP and CGRP are elevated in external jugular venous blood during a migraine attack and trigger the sterile neurogenic inflammation of the blood vessel walls. Further, A2AR is the molecular target of the receptor antagonist caffeine, which is effective in the treatment of migraine attacks in combination with analgesic drugs (5, 6). Due to the central modulation of CGRP and VIP actions and the efficacy of caffeine in the treatment of migraine, we hypothesized that variation in the A2AR gene might contribute to susceptibility to migraine. To test this hypothesis, migraine patients with and without aura and migraine-free controls 177
2 178 C Hohoff et al. Table 1 A2AR allele and haplotype frequencies in MA and MoA patients and migraine-free controls SNP ID Alleles Controls MA P MoA P rs G 156 (0.52) 126 (0.51) (0.56) 0.22 A 150 (0.48) 116 (0.49) 125 (0.44) rs C 244 (0.77) 185 (0.80) (0.80) 0.95 T 62 (0.23) 55 (0.20) 57 (0.20) rs C 177 (0.61) 148 (0.58) (0.57) 0.77 T 129 (0.39) 96 (0.42) 124 (0.43) rs C 176 (0.61) 148 (0.58) (0.57) 0.83 T 130 (0.39) 96 (0.42) 124 (0.43) rs T 176 (0.61) 149 (0.58) (0.57) (0.39) 95 (0.42) 124 (0.43) rs G 167 (0.60) 141 (0.55) (0.53) 0.55 C 137 (0.40) 95 (0.45) 135 (0.47) Haplotypes GCTT-C 127 (0.41) 92 (0.38) (0.43) 0.78 ACCCTG 87 (0.29) 60 (0.25) (0.24) 0.21 ATCCTG 61 (0.20) 52 (0.21) (0.19) 0.86 GCCCTG 18 (0.06) 30 (0.12) * 26 (0.09) 0.13 GCCCTC 9 (0.03) 4 (0.02) (0.04) 0.40 Values in parentheses are ratios. A2AR, adenosine A 2A receptor; MA, migraine with aura; MoA, migraine without aura. *Significant after cycles of permutation testing (P < 0.05). were compared for the frequency of six genetic variants spanning the A2AR gene. Patients and methods Subjects We extended our previously described sample of 197 patients with migraine (7) to 265 patients (222 women, 43 men; age years) by recruitment from the Headache Clinics of the Universities of Würzburg and Homburg, after informed consent and approval by the local ethics committees. Patients were diagnosed according to the 2nd edition of the International Classification of Headache Disorders after completion of a standardized headache questionnaire and full neurological examination. A subgroup of 122 patients had migraine with aura (MA; 96 women, age and 26 men, age years), whereas the remaining 143 patients had migraine without aura (MoA; 126 women, age years and 17 men, age years). We did not further subdivide patients with MA into subgroups. The 154 control subjects (111 women, 43 men; age years) were negative for any history of migraine, i.e. they had never had migraine in the past or present. A complete neurological history was taken and a complete neurological physical examination of the controls was also performed. Moreover, persons with a positive family history of migraine were excluded from the control group. Finally, to exclude the possibility of any late-onset migraine, we chose to recruit control probands with a minimum age of 55 years. For all subjects depression and other comorbid psychiatric disorders were excluded by history and a score of <10 on the Beck Depression Index. All subjects were of German Caucasian origin (recorded by personal interviews). Genotyping DNA was isolated from venous blood samples using standard protocols. Genotyping of the validated exonic A2AR gene polymorphisms (rs , rs and rs ; Table 1) was carried out by polymerase chain reaction (PCR)- based restriction fragment length polymorphism assays or single-strand conformation polymorphism analysis, as previously described (8, 9). Three additional polymorphisms covering the intronic and the 5 and 3 flanking regions (rs , rs and rs from the Hapmap database rel#16, on NCBI B34 assembly, dbsnp b124, were genotyped by TaqMan 5 -exonuclease assays using different coloured fluorophores for allele labelling and allelic discrimination by fluorescence signal detection (Applied Biosystems, Darmstadt, Germany). Preparation of PCR reaction mixtures was performed by Genesis Workstation RSP 150 (Tecan, Crailsheim, Germany). For PCR amplification and allelic
3 An A2AR gene haplotype is associated with MA 179 discrimination the ABI Prism 7900 Sequence Detection System and SDS software version 2.1 (Applied Biosystems) were used. All genotypes were determined blind to the disease status. A2AR: exon Statistical analysis Clinical symptoms and history data (frequency of nausea, vomiting, photophobia, phonophobia, unilateral pain, pulsating pain, mean intensity of pain, mean duration of one attack, age, mean age at onset and mean number of first-degree relatives with migraine) were compared between 122 MA patients and 143 MoA patients by Mann Whitney U-test for non-parametric variables and t-test for parametric variables. Hardy Weinberg equilibrium, linkage disequilibrium and allele-based association analyses of single markers and haplotypes were analysed by Haploview (10) version 3.2 ( Correction for multiple testing was done by the permutation method implemented in Haploview. Results No differences were detected between the 122 MA patients and the 143 MoA patients regarding the clinical symptoms and history data (all P-values >0.1), except for the presence or absence of aura. All six polymorphic variants (SNPs) of the A2AR gene were in Hardy Weinberg equilibrium (P > 0.1) and in high linkage disequlibrium (LD) (Fig. 1). This led to one haplotype block spanning all six markers and containing five different haplotype alleles with frequencies >1.0%. Of these alleles, haplotype G-C-C-C-T-G was more frequent in the MA patients (12%) than in the control group (6%, P < 0.01). In contrast, the MoA patients showed no significant difference compared with the control group. No significant difference between the three groups existed at the single-marker level (Table 1). Discussion The major finding of the current study is that variation in the A2AR gene modulates susceptibility to MA. A particular haplotype is significantly associated with MA but not MoA when compared with the migraine-free control group. This finding is consistent with epidemiological twin studies indicating a higher heritability for MA compared with MoA (11). The fact that our patients were selected from specialized headache clinics, however, may limit the implications of our study. rs rs Block 1 (41 kb) rs Figure 1 The six adenosine A 2A receptor (A2AR) gene markers represent one block of high linkage disequlibrium (LD) (block assignment based on confidence intervals) with pairwise standardized LD coefficient r 2 > 0.16 and D >0.93; D values are given as numbers in boxes, except for D = 1.0 (= empty boxes), shades of grey indicate extent of LD with darker grey = higher LD. The intermarker distances and the marker positions are indicated relative to the A2AR gene (Vertebrate Genome Annotation database, Vega v16: OTTHUMT ), which contains five exons with the translated region spanning exons 4 5 (given as black bars). Assuming that patients with the most severe forms of migraine are mostly referred to a headache clinic, our results may not necessarily be transferrable to the general population of patients with MA. The A2AR modulates the effect of CGRP and VIP in the brain. Thus, activation of the receptor leads to excitatory actions of CGRP on synaptic transmission in the hippocampal CA1 area (12). Second, A2AR agonists enhance the excitatory action of VIP on GABA release (4). Therefore an influence of A2AR activation may be related to migraine pathophysiology by enhancing CGRP and VIP actions after their release. Furthermore, N-methyl D-aspartate (NMDA) receptor-mediated currents are inhibited by adenosine A 1 receptor activation. Activation of A2AR attenuates the inhibitory rs rs rs
4 180 C Hohoff et al. capacity of A 1 receptors (3), thus facilitating NMDA receptor-mediated transmission, which is supposed to play a role in the generation of migraine aura (13). Therefore, the A2AR may also influence the genesis of the putative aura equivalent, spreading depression, by influencing signalling of ion channels. There are very few data concerning the relation between migraine aura and VIP. VIP also potentiates the effect of glutamate-mediated neurotransmission in cortical neurons, astrocytes and intraparenchymal microvessels (14). Additionally, an interesting case report discussed a new manifestation of MA due to a VIP producing left atrial myxoma and the resolution of the migraine aura after resection of the tumour (15). Caffeine, on the other hand, is an antagonist of A2AR, and combinations of caffeine with acetylsalicylic acid and paracetamol are more effective than the combination without caffeine in the acute treatment of migraine attacks (6). It would be interesting to study whether MA patients with the G-C-C-C- T-G haplotype of the A2AR gene repond to the antimigraine effects of caffeine more favourably than others. This may form the basis of future studies on the pharmacogenomics of caffeine and migraine. Polymorphisms of the A2AR gene have previously been investigated in certain forms of anxiety. For example, the exonic rs polymorphism of the A2AR gene was shown to be associated with panic disorder (8, 16). In contrast to patients with migraine, however, patients with panic disorder, as well as a subgroup of healthy controls, respond adversely to caffeine (9). This contrasting effect of caffeine suggests that opposite allelic variants of the A2AR gene should modify the risk of developing MA and panic disorder, respectively. Indeed, this is born out by the observation that in panic disorder and in caffeine-induced anxiety in healthy controls the observed association was with the T-allele of rs (1976C/T) (8, 9), whereas in MA an association is found with a haplotype containing the C-allele at this position. Thus, opposite alleles at A2AR gene position rs modulate the risk for MA and anxiety, which suggests a functional role for this variant. Our results are further supported by findings in mice lacking the A2AR. Loss of A2AR function is associated with hypoalgesia, but an increase in anxiety (17). This is consistent with the notion that activation of A2AR exerts opposite effects on pain and anxiety, thus underscoring our findings in patients. As the situation in polygenic diseases is very complex and multiple genetic and psychosocial factors contribute to the pathogenesis of anxiety disorders and migraine, this opposite effect of A2AR variants relates to only one aspect of the pathophysiology of both disorders and does not suggest a dichotomy in their aetiopathogenesis, a notion which is supported by a report of increased comorbidity of anxiety and migraine (18). While the present results are suggestive of a role of A2AR in MA, replication studies in independent, preferably family-based samples are warranted. Similarly, in vitro cell culture and in vivo animal studies are needed to define the functional consequences of the investigated A2AR gene polymorphisms. In summary, this is the first study showing that variation in the gene of the A2AR has a role in the pathophysiology of migraine with aura. Acknowledgements This study was supported by the Deutsche Forschungsgemeinschaft (SFB 581) and the IZKF Würzburg (N-2, 01KS9603). We gratefully acknowledge the expert technical assistance of K. Schwarte. References 1 Estevez M, Gardner KL. Update on the genetics of migraine. Hum Genet 2004; 114: Goadsby PJ, Kullmann DM. Another migraine gene. Lancet 2005; 366: Goadsby PJ, Hoskin KL, Storer RJ, Edvinsson L, Connor HE. A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain 2002; 125: Sebastiao AM, Ribeiro JA. Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 2000; 21: Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55: Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebocontrolled parallel group study. Cephalalgia 2005; 25: Marziniak M, Mössner R, Schmitt A, Lesch KP, Sommer C. A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology 2005; 64: Deckert J, Nothen MM, Franke P, Delmo C, Fritze J, Knapp M et al. Systematic mutation screening and association study of the A 1 and A 2A adenosine receptor genes in panic disorder suggest a contribution of the A 2A gene to the development of disease. Mol Psychiatry 18; 3:81 5.
5 An A2AR gene haplotype is associated with MA Alsene KM, Deckert J, Sand P, de Wit H. Association between A 2A receptor gene polymorphisms and caffeineinduced anxiety. Neuropsychopharmacology 2003; 28: Barrett JC, Fry B, Maller J, Daly MJ. Haploview. analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol 19; 45: Sebastiao AM, Macedo MP, Ribeiro JA. Tonic activation of A(2A) adenosine receptors unmasks, and of A(1) receptors prevents, a facilitatory action of calcitonin generelated peptide in the rat hippocampus. Br J Pharmacol 2000; 129: Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 14; 117: Magistretti PJ, Cardinaux JR, Martin JL. VIP and PACAP in the CNS: regulators of glial energy metabolism and modulators of glutamatergic signaling. Ann NY Acad Sci 18; 865: Kern RZ, Asa S. Left atrial myxoma presenting as migraine with aura: a VIP-induced syndrome? Headache 2005; 45: Hamilton SP, Slager SL, De Leon AB, Heiman GA, Klein DF, Hodge SE et al. Evidence for genetic linkage between a polymorphism in the adenosine A 2A receptor and panic disorder. Neuropsychopharmacology 2004; 29: Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A 2A receptor. Nature 17; 388: Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol 2005; 18:
A New Era of Migraine Management: The Challenging Landscape in Prevention
Provided by MediCom Worldwide, Inc. Supported by an educational grant from Teva Pharmaceuticals What is a Neuropeptide? Small chains of amino acids released by neural cells (neurons or glial cells) to
More informationAssociation Study of RGS2 Gene Polymorphisms with Panic Disorder in Japanese
Kobe J. Med. Sci., Vol. 55, No. 5, pp. E116-E121, 2009 Association Study of RGS2 Gene Polymorphisms with Panic Disorder in Japanese KENTARO MOURI 1, AKITOYO HISHIMOTO 1*, MASAAKI FUKUTAKE 1, NAOKI NISHIGUCHI
More informationACUTE TREATMENT FOR MIGRAINE. Cristina Tassorelli
The European Headache School 2012 ACUTE TREATMENT FOR MIGRAINE Cristina Tassorelli Headache Science Centre, IRCCS Neurological Institute C. Mondino Foundation - Pavia University Centre for Adaptive Disorders
More informationHEADACHE PATHOPHYSIOLOGY
HEADACHE PATHOPHYSIOLOGY Andrew Charles, M.D. Professor Director, UCLA Goldberg Migraine Program Meyer and Renee Luskin Chair in Migraine and Headache Studies Director, Headache Research and Treatment
More informationThe Biology of the Glutamatergic System and Potential Role in Migraine
INTERNATIONAL JOURNAL of BIOMEDICAL SCIENCE REVIEW ARTICLE The Biology of the Glutamatergic System and Potential Role in Migraine ABSTRACT Migraine is a common genetically linked neurovascular disorder.
More informationSeeking the best care for acute migraine
J Headache Pain (2002) 3:1 5 Springer-Verlag 2002 EDITORIAL Marcello Fanciullacci Seeking the best care for acute migraine M. Fanciullacci ( ) Headache Center, Department of Internal Medicine, University
More informationPrednisone vs. placebo in withdrawal therapy following medication overuse headache
doi:10.1111/j.1468-2982.2007.01488.x Prednisone vs. placebo in withdrawal therapy following medication overuse headache L Pageler 1,2, Z Katsarava 2, HC Diener 2 & V Limmroth 1,2 1 Department of Neurology,
More informationAssociation of CALCA and RAMP1 gene polymorphisms with migraine in a Chinese population
Neurology Asia 2017; 22(3) : 221 225 Association of CALCA and RAMP1 gene polymorphisms with migraine in a Chinese population Xingkai An, Zhenzhen Yu, Jie Fang, Qing Lin, Congxia Lu, Qilin Ma, Hongli Qu
More informationCGRP, MONOCLONAL ANTIBODIES AND SMALL MOLECULES (-GEPANTS)
CGRP, MONOCLONAL ANTIBODIES AND SMALL MOLECULES (-GEPANTS) Hans-Christoph Diener Senior Professor of Clinical Neurosciences University Duisburg-Essen Germany CGRP, Monoclonal Antibodies and Small Molecules
More informationBST227 Introduction to Statistical Genetics. Lecture 4: Introduction to linkage and association analysis
BST227 Introduction to Statistical Genetics Lecture 4: Introduction to linkage and association analysis 1 Housekeeping Homework #1 due today Homework #2 posted (due Monday) Lab at 5:30PM today (FXB G13)
More informationMigraine Pathophysiology. Robert E. Shapiro, MD, PhD
Migraine Pathophysiology Robert E. Shapiro, MD, PhD Disclosures Eli Lilly Member, Clinical Trials Data Monitoring Committee Learning Objectives By the end of this course participants will be able to describe:
More informationMIGRAINE A CAUSE OF INTENSE THROBBING; A MINI REVIEW
IJBPAS, January, 2016, 5(1): 87-92 ISSN: 2277 4998 MIGRAINE A CAUSE OF INTENSE THROBBING; A MINI REVIEW MUHAMMAD ZAMAN 1*, RABIA HASSAN 1, MUHAMMAD SHAFEEQ UR RAHMAN 2, MUHAMMAD HAFIZ ARSHAD 3, SYED ATIF
More informationLack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims
Kobe J. Med. Sci., Vol. 53, No. 4, pp. 151-155, 2007 Lack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims KAORU SAKURAI 1, NAOKI NISHIGUCHI 2, OSAMU SHIRAKAWA 2,
More informationChronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary
Chronic Migraine in Primary Care December 11 th, 2017 Werner J. Becker University of Calgary Disclosures Faculty: Werner J. Becker Relationships with commercial interests: Grants/Research Support: Clinical
More informationAssociation between interleukin-17a polymorphism and coronary artery disease susceptibility in the Chinese Han population
Association between interleukin-17a polymorphism and coronary artery disease susceptibility in the Chinese Han population G.B. Su, X.L. Guo, X.C. Liu, Q.T. Cui and C.Y. Zhou Department of Cardiothoracic
More informationZomig. Zomig / Zomig-ZMT (zolmitriptan) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: November 30, 2018 Zomig Description Zomig / Zomig-ZMT
More informationGenotype phenotype correlation in migraine without aura focusing on the rs variant on 8q22.1
J Headache Pain (2012) 13:21 27 DOI 10.1007/s10194-011-0386-5 ORIGINAL Genotype phenotype correlation in migraine without aura focusing on the rs1835740 variant on 8q22.1 Anne Francke Christensen Han Le
More informationDisclosures for Prof D L Hay. Research funding: Alder Biopharmaceuticals Inc. Consulting arrangements: Intarcia Therapeutics Inc.
Disclosures for Prof D L Hay Research funding: Alder Biopharmaceuticals Inc. Consulting arrangements: Intarcia Therapeutics Inc. CGRP & Its Receptors Debbie L Hay University of Auckland, New Zealand There
More informationMigraine and hormonal contraceptives
Migraine and hormonal contraceptives Department of Community Medicine, Systems Epidemiology University of Tromsø, November 2017 Nora Stensland Bugge Medical research student Presentation outline What is
More informationLearning objectives 6/20/2018
Cognitive impairment of patients with chronic migraine, in a neuropsychological assessment, does not depend on the use of topiramate or comorbidities Ferreira KS, MD, PhD Professor, Neurology Clinic, Medicine
More informationCluster headache (CH): epidemiology, classification and clinical picture
Cluster headache (CH): epidemiology, classification and clinical picture Toomas Toomsoo, M.D. Head of the Center of Neurology East Tallinn Central Hospital 1 INTRODUCTION Cluster headache - known as trigeminal
More informationThe Brainstem Migraine Generator - PET Studies in Migraine (1995) Migraine as a Channelopathy? Research From the Genetic Perspective (1996) Meningeal
The Brainstem Migraine Generator - PET Studies in Migraine (1995) Migraine as a Channelopathy? Research From the Genetic Perspective (1996) Meningeal Sensitization, Central Sensitization, and Allodynia
More informationGenetics and Pharmacogenetics in Human Complex Disorders (Example of Bipolar Disorder)
Genetics and Pharmacogenetics in Human Complex Disorders (Example of Bipolar Disorder) September 14, 2012 Chun Xu M.D, M.Sc, Ph.D. Assistant professor Texas Tech University Health Sciences Center Paul
More informationIntroduction to the Genetics of Complex Disease
Introduction to the Genetics of Complex Disease Jeremiah M. Scharf, MD, PhD Departments of Neurology, Psychiatry and Center for Human Genetic Research Massachusetts General Hospital Breakthroughs in Genome
More informationMigraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification
28 Primary Care Medicine Principles and Practice 29 October 28 Professor Peter J. Goadsby Peter.Goadsby@headache.ucsf.edu Department of Neurology Headache International Headache Society Classification
More informationSeizure: the clinical manifestation of an abnormal and excessive excitation and synchronization of a population of cortical
Are There Sharing Mechanisms of Epilepsy, Migraine and Neuropathic Pain? Chin-Wei Huang, MD, PhD Department of Neurology, NCKUH Basic mechanisms underlying seizures and epilepsy Seizure: the clinical manifestation
More informationThe prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients
Blackwell Publishing LtdOxford, UKCHACephalalgia0333-1024Blackwell Science, 20062006261012091213Original ArticleThe prevalence of premonitory symptoms in migrainegg Schoonman et al. The prevalence of premonitory
More informationGenome-wide Association Analysis Applied to Asthma-Susceptibility Gene. McCaw, Z., Wu, W., Hsiao, S., McKhann, A., Tracy, S.
Genome-wide Association Analysis Applied to Asthma-Susceptibility Gene McCaw, Z., Wu, W., Hsiao, S., McKhann, A., Tracy, S. December 17, 2014 1 Introduction Asthma is a chronic respiratory disease affecting
More informationPathophysiology of Migraine
Pathophysiology of Migraine 1 MIGRAINE PATHOPHYSIOLOGY: A NEUROVASCULAR HEADACHE Objectives Review the neurobiology of migraine - Features of acute attack - neuroanatomical substrates Discuss the current
More informationNEUROTRANSMITTERS IN ALCOHOLISM : A GENETIC PERSPECTIVE By Niladri Banerjee M.Tech (Biotechnology) Section-A Amity Institute of
NEUROTRANSMITTERS IN ALCOHOLISM : A GENETIC PERSPECTIVE By Niladri Banerjee M.Tech (Biotechnology) 2011-2013 Section-A Amity Institute of Biotechnology Why the topic A novel topic, not usually covered
More informationClinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.
OVERVIEW Refractory headaches and update on novel treatment Definition of refractory headache Treatment approach Medications Neuromodulation In the pipeline Juliette Preston, MD OHSU Headache Center Refractory
More informationThe Clinical Profile of Sumatriptan: Cluster Headache Key Words
Paper Eur Neurol 1994;34(suppl 2):35-39 P.J. Peter J. Goadsby Department of Neurology, The Prince Henry Hospital, Little Bay, Sydney, NSW, Australia The Clinical Profile of Sumatriptan: Cluster Headache
More informationUse of Genetics to Inform Drug Development of a Novel Treatment for Schizophrenia
Use of Genetics to Inform Drug Development of a Novel Treatment for Schizophrenia March 21, 2012 Institute of Medicine: New Paradigms in Drug Discovery Workshop Laura K. Nisenbaum, PhD Translational Medicine,
More informationDoing more with genetics: Gene-environment interactions
2016 Alzheimer Disease Centers Clinical Core Leaders Meeting Doing more with genetics: Gene-environment interactions Haydeh Payami, PhD On behalf of NeuroGenetics Research Consortium (NGRC) From: Joseph
More informationGet ahead of the ACHE: Monoclonal Antibodies in Migraine Prevention
Get ahead of the ACHE: Monoclonal Antibodies in Migraine Prevention Amanda Janisch, PharmD PGY2 Ambulatory Care Pharmacy Resident MCHS SWMN, Mankato, MN 2018 MFMER slide-1 Disclosures No financial interest
More informationDrug Metabolism Disposition
Drug Metabolism Disposition The CYP2C19 intron 2 branch point SNP is the ancestral polymorphism contributing to the poor metabolizer phenotype in livers with CYP2C19*35 and CYP2C19*2 alleles Amarjit S.
More informationHETEROGENEITY IN MIGRAINE: MANY GENES FOR MANY PHENOTYPES?
HETEROGENEITY IN MIGRAINE: MANY GENES FOR MANY PHENOTYPES? Barbara Martini*, Gaetano S. Grieco*, Daniela Fortini*, **, Alfredo Costa*, ***, Giuseppe Nappi*, **, ***, Filippo M. Santorelli*, ** * IRCCS
More informationADVANCES IN MIGRAINE MANAGEMENT
ADVANCES IN MIGRAINE MANAGEMENT Joanna Girard Katzman, M.D.MSPH Assistant Professor, Dept. of Neurology Project ECHO, Chronic Pain Program University of New Mexico Outline Migraine throughout the decades
More informationCalcitonin Gene-Related Peptide as a Biomarker in Migraine
Original Article J Neurol Res. 2017;7(6):103-107 Calcitonin Gene-Related Peptide as a Biomarker in Migraine Aktham Ismail Alemam a, b, Wafeek Mahmoud Alsheikh a, Ibrahim Alsayed Alahmar a Abstract Background:
More informationNeuropharmacology NOTES
Neuropharmacology NOTES Contents Topic Page # Lecture 1- Intro to Neurochemical Transmission & Neuromodulation 2 Lecture 2- Serotonin & Noradrenaline 7 Lecture 3- Acetylcholine & Dopamine 14 Lecture 4-
More informationRegulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.60 Subject: Migranal Nasal Spray Page: 1 of 5 Last Review Date: November 30, 2018 Migranal Nasal Spray
More information5/2/18. After this class students should be able to: Stephanie Moon, Ph.D. - GWAS. How do we distinguish Mendelian from non-mendelian traits?
corebio II - genetics: WED 25 April 2018. 2018 Stephanie Moon, Ph.D. - GWAS After this class students should be able to: 1. Compare and contrast methods used to discover the genetic basis of traits or
More informationVariants in Human Prostacyclin Receptor Gene in Patients with Migraine Headache
Iran J Psychiatry 2018; 13: 4: 239-243 Original Article Variants in Human Prostacyclin Receptor Gene in Patients with Migraine Headache Fariborz Khorvash 1, Majid Kheirollahi 2*, Mohammad Kazemi 2, Gilda
More informationLack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population
Lack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population J. Zhu 1 *, F. He 2 *, D.D. Zhang 2 *, J.Y. Yang 2, J. Cheng 1, R. Wu 1, B. Gong 2, X.Q. Liu
More informationUNDERSTANDING CHRONIC MIGRAINE. Learn about diagnosis, management, and treatment options for this headache condition
UNDERSTANDING CHRONIC MIGRAINE Learn about diagnosis, management, and treatment options for this headache condition 1 What We re Going to Cover Today The symptoms and phases of migraine Differences between
More informationDISCLOSURES FUNCTIONS OF THE HYPOTHALAMUS
NOVEL THERAPEUTIC TARGETS: THE HYPOTHALAMUS Andrew Charles, M.D. Professor Director, UCLA Goldberg Migraine Program Meyer and Renee Luskin Chair in Migraine and Headache Studies David Geffen School of
More informationPathophysiology of Headache Past and Present
Headache ISSN 0017-8748 C 2007 the Author doi: 10.1111/j.1526-4610.2007.00678.x Journal compilation C 2007 American Headache Society Published by Blackwell Publishing Pathophysiology of Headache Past and
More informationA new questionnaire for assessment of adverse events associated with triptans: methods of assessment influence the results. Preliminary results
J Headache Pain (2004) 5:S112 S116 DOI 10.1007/s10194-004-0123-4 Michele Feleppa Fred D. Sheftell Luciana Ciannella Amedeo D Alessio Giancarlo Apice Nino N. Capobianco Donato M.T. Saracino Walter Di Iorio
More informationComorbidities of Migraine
Comorbidities of Migraine Richard B. Lipton, MD Edwin S Lowe Professor and Vice Chair of Neurology Director, Montefiore Headache Center Albert Einstein College of Medicine Overview What is comorbidity?
More informationOCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA
OMED 17 OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA 29.5 Category 1-A CME credits anticipated ACOFP / AOA s 122 nd Annual Osteopathic Medical Conference & Exposition Joint Session with ACOFP, ACONP and AOAAM:
More informationSpecific features of migraine syndrome in children
J Headache Pain (2006) 7:206 210 DOI 10.1007/s10194-006-0312-4 RAPID COMMUNICATION Marija Knezevic-Pogancev Specific features of migraine syndrome in children Received: 16 April 2006 Accepted in revised
More informationTCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden
(2007) 15, 342 346 & 2007 Nature Publishing Group All rights reserved 1018-4813/07 $30.00 ARTICLE www.nature.com/ejhg TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden Sofia Mayans
More informationUniversity of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke
University of Groningen Metabolic risk in people with psychotic disorders Bruins, Jojanneke IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
More informationTears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE
Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE IHS Classification 1989 (updated 2004) Primary Headaches 4 categories Migraine Tension-type Cluster and other trigeminal
More informationEmbriologically, The head is formed from the first two cervical segments (except the mandible, which is formed by the third). The first and second
Embriologically, The head is formed from the first two cervical segments (except the mandible, which is formed by the third). The first and second cervical vertebra are also derived from these two segments.
More informationIs OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20
1 2 3 4 5 6 Is OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20 years Efficacy of BoNT type A (onabotulinumtoxina,
More informationTryptophan Hydroxylase 2 Gene Polymorphisms in Japanese Patients with Medication Overuse Headaches
Original Articles 147 Tryptophan Hydroxylase 2 Gene Polymorphisms in Japanese Patients with Medication Overuse Headaches Masakazu Ishii 1, Hirotaka Katoh 2, Tomomi Onaya 1,3, Hideyo Kasai 2, Mitsuru Kawamura
More informationAdvances in the Treatment of Migraine
Advances in the Treatment of Migraine C. Philip O Carroll, M.D. Director Neurobehavioral Medicine Hoag Neurosciences Institute Guyuron B Headache, 2015;55:1464-1473 I m sorry your head hurts, sweetie.is
More informationRelationship between genetic polymorphisms in the DRD5 gene and paranoid schizophrenia in northern Han Chinese
Relationship between genetic polymorphisms in the DRD5 gene and paranoid schizophrenia in northern Han Chinese Y. Zhao, M. Ding, H. Pang, X.M. Xu and B.J. Wang Department of Forensic Medicine, China Medical
More informationDan Koller, Ph.D. Medical and Molecular Genetics
Design of Genetic Studies Dan Koller, Ph.D. Research Assistant Professor Medical and Molecular Genetics Genetics and Medicine Over the past decade, advances from genetics have permeated medicine Identification
More informationMRC-Holland MLPA. Description version 14; 28 September 2016
SALSA MLPA probemix P279-B3 CACNA1A Lot B3-0816. As compared to version B2 (lot B2-1012), one reference probe has been replaced and the length of several probes has been adjusted. Voltage-dependent calcium
More informationVASOPRESSIN: from VNTRs to cellular mechanisms to emotion the fraught nonapeptide
VASOPRESSIN: from VNTRs to cellular mechanisms to emotion the fraught nonapeptide We first examined the arginine vasopressin 1a receptor (AVPR1a) promoter region microsatellites (allele frequencies
More informationGreg Book. September 25, 2007 Olin Neuropsychiatry Research Center
Migraine Pathogenesis Greg Book September 25, 2007 Olin Neuropsychiatry Research Center Migraine Migraine i affects approximately 19.2% of females and 6.6% of males in the United States. (Patel, Bigal
More informationMigraine Controversies in Women s Health. Professor Peter J. Goadsby 5 December Department of Neurology
Migraine 2008 Controversies in Women s Health 5 December 2008 Professor Peter J. Goadsby Peter.Goadsby@headache.ucsf.edu Department of Neurology Headache International Headache Society Classification Primary
More informationImaging Genetics: Heritability, Linkage & Association
Imaging Genetics: Heritability, Linkage & Association David C. Glahn, PhD Olin Neuropsychiatry Research Center & Department of Psychiatry, Yale University July 17, 2011 Memory Activation & APOE ε4 Risk
More informationReview of Neurochemistry What are neurotransmitters?
Review of Neurochemistry What are neurotransmitters? In molecular terms, neurotransmitters are molecules that ( ) and of neurons by, for example, increasing or decreasing enzymatic activity or altering
More informationDepartment of Psychiatry, Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China
Association study of suppressor with morphogenetic effect on genitalia protein 6 (SMG6) polymorphisms and schizophrenia symptoms in the Han Chinese population Hongyan Yu 1,, Yongfeng Yang 1,2,3,, Wenqiang
More informationClasses of Neurotransmitters. Neurotransmitters
1 Drugs Outline 2 Neurotransmitters Agonists and Antagonists Cocaine & other dopamine agonists Alcohol & its effects / Marijuana & its effects Synthetic & Designer Drugs: Ecstasy 1 Classes of Neurotransmitters
More informationGlobal variation in copy number in the human genome
Global variation in copy number in the human genome Redon et. al. Nature 444:444-454 (2006) 12.03.2007 Tarmo Puurand Study 270 individuals (HapMap collection) Affymetrix 500K Whole Genome TilePath (WGTP)
More informationARxCH. Annual Review of Changes in Healthcare. Calcitonin Gene-Related Peptide Receptors and the Prevention of Migraines. Abstract
Calcitonin Gene-Related Peptide Receptors and the Prevention of Migraines Brian Schuler, PharmD Candidate 2018 1 1 University of Findlay College of Pharmacy Abstract Migraines are the third most prevalent
More informationIs Topiramate Effective in Preventing Pediatric Migraines?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2013 Is Topiramate Effective in Preventing
More informationZomig. Zomig / Zomig-ZMT (zolmitriptan) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: March 16, 2018 Zomig Description Zomig / Zomig-ZMT
More informationAn Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California
An Overview of MOH IHS ASIAN HA MASTERS SCHOOL MARCH 24, 2013 ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California President-Elect
More informationGenetics of Behavior (Learning Objectives)
Genetics of Behavior (Learning Objectives) Recognize that behavior is multi-factorial with genetic components Understand how multi-factorial traits are studied. Explain the terms: incidence, prevalence,
More informationVariants in the human potassium channel gene (KCNN3) are associated with migraine in a high risk genetic isolate
Variants in the human potassium channel gene (KCNN3) are associated with migraine in a high risk genetic isolate Author Cox, Hannah, Lea, Rodney, Bellis, Claire, Carless, Melanie, Dyer, Tom, Blangero,
More informationA family-based association study of DNA sequence variants in GRM7 with schizophrenia in an Indonesian population
International Journal of Neuropsychopharmacology (2009), 12, 1283 1289. Copyright f CINP 2009 doi:10.1017/s1461145709990356 A family-based association study of DNA sequence variants in GRM7 with schizophrenia
More informationJay M. Baraban MD, PhD January 2007 GENES AND BEHAVIOR
Jay M. Baraban MD, PhD jay.baraban@gmail.com January 2007 GENES AND BEHAVIOR Overview One of the most fascinating topics in neuroscience is the role that inheritance plays in determining one s behavior.
More informationUKPMC Funders Group Author Manuscript Mol Psychiatry. Author manuscript; available in PMC 2009 January 22.
UKPMC Funders Group Author Manuscript Published in final edited form as: Mol Psychiatry. 2008 July ; 13(7): 658 660. doi:10.1038/mp.2008.47. D-Amino acid oxidase (DAO) activity and expression are increased
More informationGenetics of Behavior (Learning Objectives)
Genetics of Behavior (Learning Objectives) Recognize that behavior is multi-factorial with genetic components Understand how multi-factorial traits are studied. Explain the terms: prevalence, incidence,
More informationEffects of Stratification in the Analysis of Affected-Sib-Pair Data: Benefits and Costs
Am. J. Hum. Genet. 66:567 575, 2000 Effects of Stratification in the Analysis of Affected-Sib-Pair Data: Benefits and Costs Suzanne M. Leal and Jurg Ott Laboratory of Statistical Genetics, The Rockefeller
More informationValue of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an example
J Headache Pain (2006) 7:27 33 DOI 10.1007/s10194-006-0266-6 ORIGINAL Julio Pascual Hans-Christoph Diener Hélène Massiou Value of postmarketing surveillance studies in achieving a complete picture of antimigraine
More informationDifferences of anti-nociceptive mechanisms of migraine drugs on the trigeminal pain processing during and outside acute migraine attacks
Blackwell Science, LtdOxford, UKCHACephalalgia1468-2982Blackwell Publishing, 04248657662Original ArticleAnti-nociceptive mechanisms of migraine drugs Z Katsarava et al. doi:10.1111/j.1468-2982.04.00730.x
More informationSection: Chapter 5: Multiple Choice. 1. The structure of synapses is best viewed with a(n):
Section: Chapter 5: Multiple Choice 1. The structure of synapses is best viewed with a(n): p.155 electron microscope. light microscope. confocal microscope. nissle-stained microscopic procedure. 2. Electron
More informationSpecific Objectives A. Topics to be lectured and discussed at the plenary sessions
Specific Objectives A. Topics to be lectured and discussed at the plenary sessions 0. Introduction: Good morning ICHD-III! Let s start at the very beginning. When you read you begin with A-B-C, so when
More informationOriginal Article. C18orf1 located on chromosome 18p11.2 may confer susceptibility to schizophrenia
J Med Dent Sci 2003; 50: 225 229 Original Article C18orf1 located on chromosome 18p11.2 may confer susceptibility to schizophrenia Mika Kikuchi 1,2, Kazuo Yamada 1, Tomoko Toyota 1,2 and Takeo Yoshikawa
More informationMigraine much more than just a headache
Migraine much more than just a headache Session hosted by Teva UK Limited PUU4 11:15 12:15 UK/NHSS/18/0021b Date of Preparation: August 2018 The views expressed in this presentation are those of the speaker
More informationFaculty Disclosures. Learning Objectives
WWW.AMERICANHEADACHESOCIETY.ORG Pathophysiology Content developed by: Andrew C. Charles, MD, FAHS, Peter J. Goadsby, MD, PhD, FAHS Donna Gutterman, PharmD Faculty Disclosures ANDREW C. CHARLES, MD, FAHS
More informationObesity is a risk factor for transformed migraine but not chronic tension-type headache
Obesity is a risk factor for transformed migraine but not chronic tension-type headache Marcelo E. Bigal and Richard B. Lipton Neurology 2006;67;252 DOI 10.1212/01.wnl.0000225052.35019.f9 This information
More informationThe PACAP Receptor: A Novel Target for Migraine Treatment
DEPARTMENT OF NEUROLOGY D A N I& S DANISH H H E AHEADACHE D A C H E CENTER C E N T E R Faculty of Health and Medical Sciences The PACAP Receptor: A Novel Target for Migraine Treatment Messoud Ashina, MD,
More informationPolymorphic Variations in 5 HT2A, 5 HTT and DISC 1 in first episode schizophrenia patients
PolymorphicVariationsin5 HT2A,5 HTTandDISC1infirst episodeschizophreniapatients L.MedinaGonzález,DepartmentofClinicalChemistry,RamónyCajalHospital,Madrid. PhD.MJArranz,SectionofClinicalNeuropharmacologyattheInstituteofPsychiatry,
More information10/19/2018. Disclosures MIGRAINE PROPHYLAXIS. Objectives. Definitions Slide. What do you think the aooe stands for at the end of erenumab-aooe?
Disclosures MIGRAINE PROPHYLAXIS Erenumab-aooe (AIMOVIG TM ) Calcitonin Gene Related Peptide Receptor Antagonist No conflicts of interest to disclose Chelsey Roscoe, PharmD PGY1 Resident - CTVHCS 2 3 Definitions
More informationMIGRAINES RESEARCH PRESENTATION ONE
MIGRAINES RESEARCH PRESENTATION ONE GROUP 4 Miguel Cardoso, Shara Chowdhury, Sabrina Musto, Harpreet Pabla, Ojan Yarkhani. LIFESCI 4M03 Research Seminar Instructor Dr. Daniel Yang 1 EPIDEMIOLOGY The incidence,
More informationThe Biology of the Glutamatergic System and Potential Role in Migraine
International journal of Biomedical science REVIEW ARTICLE The Biology of the Glutamatergic System and Potential Role in Migraine C. F. Gasparini, L. R. Griffiths Genomics Research Centre, Griffith Health
More informationCalcitonin Gene Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
The new england journal of medicine original article Calcitonin Gene Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine Jes Olesen, M.D., Hans-Christoph Diener, M.D.,
More informationSupplementary note: Comparison of deletion variants identified in this study and four earlier studies
Supplementary note: Comparison of deletion variants identified in this study and four earlier studies Here we compare the results of this study to potentially overlapping results from four earlier studies
More informationASSESSMENT OF HEADACHE IN MEN TAKING PHOSPHODIESTERASE-5 INHIBITOR (TADALAFIL) FOR ERECTILE DYSFUNCTION
Acta Medica Mediterranea, 2014, 30: 1007 ASSESSMENT OF HEADACHE IN MEN TAKING PHOSPHODIESTERASE-5 INHIBITOR (TADALAFIL) FOR ERECTILE DYSFUNCTION E. ESRA OKUYUCU*, OGUZ GUVEN**, EDIP UCAR***, TASKIN DUMAN*
More informationNeurons have cell membranes that separate them from the environment outside the neuron.
Neural Communication Lecture 11 A. Resting Potential In this section, we will consider the basic unit of the nervous system the neuron and how neurons communicate with each other. The story of neural communication
More informationSumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 0 Subject: Sumatriptan Page: 1 of 6 Last Review Date: November 30, 2018 Sumatriptan Description Sumatriptan
More informationIntroduction to Genetics and Genomics
2016 Introduction to enetics and enomics 3. ssociation Studies ggibson.gt@gmail.com http://www.cig.gatech.edu Outline eneral overview of association studies Sample results hree steps to WS: primary scan,
More informationSupraorbital nerve stimulation Cefaly Device - FDA Approved for migraine prevention (also being investigated as acute therapy)
NEUROSTIMULATION/NEUROMODULATION UPDATE Meyer and Renee Luskin Andrew Charles, M.D. Professor Luskin Chair in Migraine and Headache Studies Director, UCLA Goldberg Migraine Program David Geffen School
More information